AuntMinnie
FEBRUARY 26, 2025
Whole-body MRI is emerging as a superior tool for assessing bone marrow and monitoring therapy response in advanced breast cancer. Additionally, modalities like MRI, CT, bone scans, and PET-CT are significant contributors to greenhouse gas emissions, with radiology accounting for approximately 1% of global healthcare-related emissions.
AuntMinnie
JANUARY 30, 2024
Efforts to bring quantitative MRI analysis into clinical practice received a boost with the availability of two new Category III Current Procedural Terminology (CPT) codes for brain MRI. Effective January 1, 2024, the new codes, 0865T and 0866T, support the use of software to analyze brain MRI exams with comparison to prior studies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
NOVEMBER 12, 2024
Middlebrooks' research interest consists of using ultrahigh-field, 7-tesla MRI to plot brain microstructure and develop surgical treatment of brain tumors, epilepsy, and neurodegenerative and movement disorders such as Parkinson's disease, essential tremor, and dystonia. Middlebrooks, MD, of the Mayo Clinic in Jacksonville, FL.
AuntMinnie
OCTOBER 14, 2024
These SSTRs can be targeted both with gallium-68 (Ga-68) imaging agents and therapeutic lutetium-177 (Lu-177) radiopharmaceuticals using a so-called theranostics approach. In addition, a recent study demonstrated the cost-effectiveness of Ga-68 DOTATATE PET/MRI in the management of meningiomas in a U.S. In the U.S.,
AuntMinnie
OCTOBER 25, 2024
His research interests include using structural and functional MRI -- particularly ultrahigh-field, 7-tesla MRI -- to map brain microstructure and develop neurosurgical treatment of brain tumors, epilepsy, and neurodegenerative and movement disorders such as Parkinson's disease, essential tremor, and dystonia.
UCSF Biomedical Imaging
JANUARY 12, 2024
In 2003, the Center for Molecular and Functional Imaging (CMFI) at China Basin Landing opened its doors with San Francisco’s first 3T MRI and two 1.5T clinical scanners, followed a few years later by a cyclotron which launched our in-house radiopharmaceutical program.
Imaging Technology
JULY 9, 2024
I congratulate Marco Campione on this CEO appointment and we look forward to drawing upon his strategic, operational and broad general business expertise as we increase our global leadership throughout the diagnostic radiopharmaceutical industry,” said Fulvio Renoldi Bracco, CEO of Bracco Imaging. Bracco Imaging S.p.A.,
Expert insights. Personalized for you.
130 
Let's personalize your content